BANG-BIN CHENPO-CHIN LIANGTIFFANY TING-FANG SHIHTSUNG-HAO LIUYING-CHUN SHENLI-CHUN LUZHONG-ZHE LINCHIUN HSUCHIH-HUNG HSUANN-LII CHENGYU-YUN SHAO2022-11-072022-11-072023-07-210938-7994https://scholars.lib.ntu.edu.tw/handle/123456789/624492To investigate the association of sarcopenia, myosteatosis, and sarcopenic obesity with survival outcomes among patients who underwent immunotherapy for advanced hepatocellular carcinoma (HCC).enHepatocellular carcinoma; Immunotherapy; Myosteatosis; Sarcopenia; Survival[SDGs]SDG2[SDGs]SDG3[SDGs]SDG5Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinomajournal article10.1007/s00330-022-08980-4358643512-s2.0-85134587833WOS:000828464100002https://scholars.lib.ntu.edu.tw/handle/123456789/624040